{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:49Z","timestamp":1786985089249,"version":"build-2736575974"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.beem.2025.101975","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:46:59Z","timestamp":1736477219000},"page":"101975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adolescent primary hyperparathyroidism"],"prefix":"10.1016","volume":"39","author":[{"given":"Anima","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba Samad","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjiri","family":"Karlekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2025.101975_bib1","article-title":"Primary hyperparathyroidism","volume":"38","author":"Silva","year":"2024","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib2","doi-asserted-by":"crossref","DOI":"10.1159\/000381622","article-title":"Aetiology, diagnosis and surgical treatment of primary hyperparathyroidism in children: new trends","author":"Alagaratnam","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2025.101975_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/endrev\/bnad009","article-title":"Molecular and clinical spectrum of primary hyperparathyroidism","volume":"44","author":"Jha","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2025.101975_bib4","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and nonclassical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2025.101975_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-022-00985-x","article-title":"Genotype-phenotype correlations in Asian Indian children and adolescents with primary hyperparathyroidism","author":"Sharma","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2025.101975_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/cen.13453","article-title":"Primary hyperparathyroidism in Chinese children and adolescents: a single-centre experience at Peking Union Medical College Hospital","volume":"87","author":"Wang","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/EJE-20-1119","article-title":"Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population","volume":"184","author":"El Allali","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2023.03.001","article-title":"Dual-phase computed tomography for localization of parathyroid lesions in children and adolescents with primary hyperparathyroidism","author":"Sharma","year":"2023","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijporl.2012.12.008","article-title":"Characterization of hyperparathyroidism in youth and adolescents: a literature review","volume":"77","author":"Belcher","year":"2013","journal-title":"Int J Pedia Otorhinolaryngol"},{"key":"10.1016\/j.beem.2025.101975_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpedsurg.2016.01.018","article-title":"Outcomes of minimally invasive parathyroidectomy in pediatric patients with primary hyperparathyroidism owing to parathyroid adenoma: a single institution experience","volume":"52","author":"Mancilla","year":"2017","journal-title":"J Pedia Surg"},{"key":"10.1016\/j.beem.2025.101975_bib11","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s00268-019-05362-8","article-title":"Single gland, ectopic location: adenomas are common causes of primary hyperparathyroidism in children and adolescents","volume":"44","author":"Rampp","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2025.101975_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.surg.2021.04.041","article-title":"Multiple endocrine neoplasia type 1 in children and adolescents: clinical features and treatment outcomes","volume":"171","author":"Shariq","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2025.101975_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.926986","article-title":"Off-label use of cinacalcet in pediatric primary hyperparathyroidism: a French multicenter experience","volume":"10","author":"Bernardor","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.beem.2025.101975_bib14","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/wjs.12329","article-title":"A retrospective database analysis of pediatric parathyroidectomies from the United Kingdom registry of endocrine and thyroid surgeons","volume":"48","author":"Embury-Young","year":"2024","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2025.101975_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.beem.2018.12.003","article-title":"Epidemiology of parathyroid disorders","volume":"32","author":"Rao","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib16","first-page":"180","article-title":"Working group on calcium metabolism. primary hyperparathyroidism in neonates and","volume":"69","author":"Mallet","year":"2008","journal-title":"Child Fr Exp (1984-2004) Horm Res"},{"key":"10.1016\/j.beem.2025.101975_bib17","author":"Aspinall","year":"2021","journal-title":"Br Assoc Endocr Thyroid Surg Sixth Natl Audit Rep"},{"key":"10.1016\/j.beem.2025.101975_bib18","first-page":"1147","article-title":"Characteristics of primary hyperparathyroidism in adolescents","volume":"21","author":"Bhadada","year":"2008","journal-title":"J Pedia Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib19","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2025.101975_bib20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1542\/peds.2004-0804","article-title":"Primary hyperparathyroidism in pediatric patients","volume":"115","author":"Kollars","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2025.101975_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jpedsurg.2014.05.032","article-title":"Surgical treatment of children with hyperparathyroidism: single centre experience","volume":"49","author":"Alagaratnam","year":"2014","journal-title":"J Pedia Surg"},{"key":"10.1016\/j.beem.2025.101975_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00268-020-05816-4","article-title":"Pediatric primary hyperparathyroidism: experience in a tertiary care referral center in a developing country over three decades","volume":"45","author":"Sharanappa","year":"2021","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2025.101975_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.beem.2025.101975_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00774-020-01142-w","article-title":"Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry","volume":"39","author":"Arya","year":"2021","journal-title":"J Bone Min Metab"},{"key":"10.1016\/j.beem.2025.101975_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.amjsurg.2022.10.018","article-title":"Pediatric primary hyperparathyroidism: Surgical pathology and long-term outcomes in sporadic and familial cases","volume":"225","author":"Szabo Yamashita","year":"2023","journal-title":"Am J Surg"},{"key":"10.1016\/j.beem.2025.101975_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4158\/EP14447.OR","article-title":"Asymptomatic primary hyperparathyroidism exists in North india: retrospective data from 2 tertiary care centers","volume":"21","author":"Mithal","year":"2015","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2025.101975_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4248\/BR201302005","article-title":"Primary hyperparathyroidism: a tale of two cities revisited \u2014 New York and Shanghai","volume":"1","author":"Liu","year":"2013","journal-title":"Bone Res"},{"key":"10.1016\/j.beem.2025.101975_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4158\/EP-2018-0268","article-title":"Primary hyperparathyroidism in the young: comparison with adult primary hyperparathyroidism","volume":"24","author":"Mukherjee","year":"2018","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2025.101975_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/jc.2012-2914","article-title":"The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center","volume":"98","author":"Zhao","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.602221","article-title":"Clinical characteristics of primary hyperparathyroidism: 15-year experience of 457 patients in a single center in China","volume":"12","author":"Lin","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5114\/pedm.2022.118315","article-title":"The spectrum of manifestations of primary hyperparathyroidism in children and adolescents","volume":"28","author":"Boro","year":"2022","journal-title":"Pedia Endocrinol Diabetes Metab"},{"key":"10.1016\/j.beem.2025.101975_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Min Metab"},{"key":"10.1016\/j.beem.2025.101975_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40618-015-0423-3","article-title":"Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss primary hyperparathyroidism cohort: a focus on neuro-behavioral and cognitive symptoms","volume":"39","author":"Trombetti","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2025.101975_bib36","article-title":"Phosphate: an underrated component of primary hyperparathyroidism","volume":"38","author":"Bhadada","year":"2024","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00383-012-3222-3","article-title":"Primary hyperparathyroidism in adolescents: the same but different","volume":"29","author":"Pashtan","year":"2013","journal-title":"Pedia Surg Int"},{"key":"10.1016\/j.beem.2025.101975_bib38","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-02789","article-title":"New Concepts About Familial Isolated Hyperparathyroidism","author":"Marx","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib39","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2007-0322","article-title":"Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population","volume":"92","author":"Nissen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib40","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1210\/jc.2008-2430","article-title":"Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years","volume":"95","author":"Guarnieri","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cen.14254","article-title":"Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort","volume":"93","author":"Mariathasan","year":"2020","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12020-017-1322-5","article-title":"MEN1 in children and adolescents: data from patients of a regional referral center for hereditary endocrine tumors","volume":"59","author":"Vannucci","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2025.101975_bib43","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the groupe d\u2019\u00e9tude des tumeurs endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib44","doi-asserted-by":"crossref","first-page":"T227","DOI":"10.1530\/ERC-17-0203","article-title":"Management impact: effects on quality of life and prognosis in MEN1","volume":"24","author":"Marini","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2025.101975_bib45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2025.101975_bib46","doi-asserted-by":"crossref","first-page":"E336","DOI":"10.1210\/jc.2012-3192","article-title":"Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening","volume":"98","author":"Machens","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/humu.21385","article-title":"Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10","volume":"32","author":"Frank-Raue","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2025.101975_bib48","doi-asserted-by":"crossref","first-page":"T41","DOI":"10.1530\/ERC-17-0202","article-title":"Advances in risk-oriented surgery for multiple endocrine neoplasia type 2","volume":"25","author":"Machens","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2025.101975_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia Type 1: latest insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2025.101975_bib50","doi-asserted-by":"crossref","first-page":"e1482","DOI":"10.1210\/clinem\/dgae055","article-title":"Beyond MEN1, when to think about MEN4? retrospective study on 5600 patients in the French population and literature review","volume":"109","author":"Chevalier","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib51","article-title":"Early Onset primary hyperparathyroidism associated with a novel germline mutation in CDKN1B","volume":"2015","author":"Elston","year":"2015","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib52","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00268-019-05156-y","article-title":"Long-term outcomes of parathyroidectomy in hyperparathyroidism-jaw tumor syndrome: analysis of five families with CDC73 mutations","volume":"44","author":"Iacobone","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2025.101975_bib53","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib54","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cen.14211","article-title":"Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: a multicentre study of 77 adult patients","volume":"93","author":"Mouly","year":"2020","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib57","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz233","article-title":"Neonatal severe hyperparathyroidism: novel insights from calcium, PTH, and the CASR gene","volume":"105","author":"Marx","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib58","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2025.101975_bib59","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.3390\/nu14224928","article-title":"Vitamin D status for Chinese children and adolescents in CNNHS 2016-2017","volume":"14","author":"Hu","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.beem.2025.101975_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21279-0","article-title":"Vitamin D status and determinants in Indian children and adolescents: a multicentre study","volume":"12","author":"Khadilkar","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2025.101975_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105695","article-title":"Effect of vitamin D nutrition on disease indices in patients with primary hyperparathyroidism","volume":"201","author":"Rao","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.beem.2025.101975_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12098-009-0289-5","article-title":"Primary hyperparathyroidism in children and adolescents","volume":"77","author":"George","year":"2010","journal-title":"Indian J Pedia"},{"key":"10.1016\/j.beem.2025.101975_bib63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4103\/ijem.IJEM_306_19","article-title":"Slipped capital femoral epiphysis in primary hyperparathyroidism - case report with literature review","volume":"23","author":"George","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib64","article-title":"The pathophysiology of hypophosphatemia","volume":"38","author":"Ito","year":"2024","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib65","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.4158\/EP15648.OR","article-title":"HRPT2- (CDC73) related hereditary hyperparathyroidism: a case series from Western India","volume":"21","author":"Khadilkar","year":"2015","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2025.101975_bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MED.0b013e32834c3c7c","article-title":"Familial hypocalciuric hypercalcaemia: a review","volume":"18","author":"Christensen","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2025.101975_bib67","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib68","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1210\/jc.2013-3593","article-title":"A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets","volume":"99","author":"Szczawinska","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib69","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1210\/jc.2004-1046","article-title":"Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor","volume":"89","author":"Miyashiro","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib70","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1210\/jc.2008-2484","article-title":"A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia","volume":"94","author":"Lietman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib71","doi-asserted-by":"crossref","first-page":"P041","DOI":"10.1055\/s-0034-1372058","article-title":"Severe but not neonatally lethal. A homozygous inactivating CaSR mutation in a 3 year old child","volume":"122","author":"Schnabel","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.beem.2025.101975_bib72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.3339","article-title":"Familial hypocalciuric hypercalcemia as an atypical form of primary hyperparathyroidism","volume":"33","author":"Marx","year":"2018","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2025.101975_bib73","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/jc.2017-02773","article-title":"Pro-FHH: a risk equation to facilitate the diagnosis of parathyroid-related hypercalcemia","volume":"103","author":"Bertocchio","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib74","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1373\/clinchem.2011.177741","article-title":"Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children","volume":"58","author":"Colantonio","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2025.101975_bib75","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/archinte.1991.00400080083015","article-title":"Use of random urine samples to estimate total urinary calcium and phosphate excretion","volume":"151","author":"G\u00f6k\u00e7e","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2025.101975_bib76","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3476(97)70162-8","article-title":"Urinary phosphate\/creatinine, calcium\/creatinine, and magnesium\/creatinine ratios in a healthy pediatric population","volume":"131","author":"Matos","year":"1997","journal-title":"J Pedia"},{"key":"10.1016\/j.beem.2025.101975_bib77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.beem.2025.101975_bib78","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.3390\/biomedicines11102810","article-title":"Pediatric neuroendocrine neoplasia of the parathyroid glands: delving into primary hyperparathyroidism","volume":"11","author":"Carsote","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.beem.2025.101975_bib79","first-page":"349","article-title":"Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature","volume":"27","author":"Kolyva","year":"2014","journal-title":"J Pedia Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib80","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/jbmr.4689","article-title":"Surgical aspects of primary hyperparathyroidism","volume":"37","author":"Perrier","year":"2022","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2025.101975_bib81","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1148\/rg.210170","article-title":"Contemporary multimodality imaging of primary hyperparathyroidism","volume":"42","author":"Naik","year":"2022","journal-title":"Radiographics"},{"key":"10.1016\/j.beem.2025.101975_bib82","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamaoto.2021.0915","article-title":"Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism: a systematic review and network meta-analysis","volume":"147","author":"Lee","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.beem.2025.101975_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s00247-024-06036-x","article-title":"[18F]fluorocholine PET\/CT in pediatric primary hyperparathyroidism","author":"Treglia","year":"2024","journal-title":"Pedia Radio"},{"key":"10.1016\/j.beem.2025.101975_bib84","doi-asserted-by":"crossref","unstructured":"Sonawane S, Jadhav SS, Goroshi M, et al. Percentage arterial enhancement on 2D CT in the diagnosis of primary hyperparathyroidism: A prospective validation study and potential pitfalls. Head & Neck n.d.;n\/a. https:\/\/doi.org\/10.1002\/hed.27108.","DOI":"10.1002\/hed.27108"},{"key":"10.1016\/j.beem.2025.101975_bib85","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cen.13406","article-title":"Percentage arterial enhancement: An objective index for accurate identification of parathyroid adenoma\/hyperplasia in primary hyperparathyroidism","volume":"87","author":"Goroshi","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib86","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-04076-9","article-title":"The polar vessel sign: insights from CT imaging analysis in Asian Indian primary hyperparathyroidism","author":"Sharma","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2025.101975_bib87","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/hed.26677","article-title":"Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort","volume":"43","author":"Shah","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.beem.2025.101975_bib88","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s00268-013-2054-1","article-title":"Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy","volume":"37","author":"Nilubol","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2025.101975_bib89","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1007\/s00268-022-06707-6","article-title":"Invited commentary: less than subtotal parathyroidectomy for multiple endocrine neoplasia type 1 primary hyperparathyroidism: a systematic review and meta-analysis","volume":"46","author":"Palazzo","year":"2022","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2025.101975_bib90","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00268-016-3624-9","article-title":"Unilateral clearance for primary hyperparathyroidism in selected patients with multiple endocrine neoplasia type 1","volume":"40","author":"Kluijfhout","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2025.101975_bib91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.surg.2013.03.004","article-title":"Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism","volume":"154","author":"Versnick","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2025.101975_bib92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cen.14112","article-title":"Single gland excision for MEN1-associated primary hyperparathyroidism","volume":"92","author":"Manoharan","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2025.101975_bib93","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1210\/clinem\/dgab240","article-title":"Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: a multicenter study","volume":"106","author":"Wei","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib94","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/diagnostics13111953","article-title":"Forestalling hungry bone syndrome after parathyroidectomy in patients with primary and renal hyperparathyroidism","volume":"13","author":"Carsote","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.beem.2025.101975_bib95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ando.2022.10.015","article-title":"Spectrum of renal dysfunction after curative parathyroidectomy in symptomatic primary hyperparathyroidism","volume":"84","author":"Gosavi","year":"2023","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.beem.2025.101975_bib96","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/jbmr.4685","article-title":"The efficacy and safety of medical and surgical therapy in patients with primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Ye","year":"2022","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2025.101975_bib97","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2005-1239","article-title":"Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance","volume":"91","author":"Guarnieri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101975_bib98","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.beem.2018.09.010","article-title":"Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism","volume":"32","author":"Cristina","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:32:57Z","timestamp":1741843977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X25000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521690X25000089"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.101975","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adolescent primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.101975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101975"}}